Introduction

Aminoverse partnered with a pharmaceutical research organization to accelerate drug discovery using enzyme-based platforms.

Challenge

Traditional drug discovery workflows were slow and inefficient due to complex synthesis routes and limited reaction selectivity.

Solution

Customized enzyme platforms were developed to enable rapid, selective, and scalable molecular transformations for screening.

Results

The platform significantly reduced discovery timelines and improved early-stage research efficiency.

Conclusion

This case highlights how enzyme platforms can accelerate pharmaceutical innovation.